Birth defects are a leading cause of infant mortality in the U.S and contribute substantially to healthcare costs and life-long disabilities. They affect 1 in every 33 babies in the U.S., which accounts for more than 20% of all infant deaths, and contribute to $2.6 billion annually in hospital costs alone.
The Centers for Disease Control https://www.cdc.gov, posted a forecasted grant notice on April 19, 2019, titled “Population-Based Rapid Surveillance of Birth Defects and Neonatal Abstinence Syndrome” (CDC-RFA-DD20-2001) which is estimated to be posted June 28, 2019.
The funding notice is going include the following objectives to:
- Expand birth defects surveillance to include neonatal abstinence syndrome
- Improve timeliness of surveillance data
- Leverage EHRs and interoperability capabilities to enhance surveillance of birth defects and neonatal abstinence syndrome
- Use surveillance data to improve health outcomes of affected populations
Eligibility is limited to U.S. State, D.C., and territorial agencies because they have public health authority and/or have a legislative mandate to conduct population-based birth defects surveillance. This authority enables them to have specific access to data multiple sources that are required to implement the activities outlined in the coming forecasted funding notice.
Go to https://www.grants.gov/custom/printForecastDetails.jsp for more information on the funding forecast posted April 19, 2019.